Internal Medicine Board
Saudi Board Internal Medicine Final Written Exam (SCFHS)
Endocrinology Rheumatology InfectiousEnglish
Exam overviewPractice session
A 62-year-old man with type 2 diabetes mellitus, Stage 3a chronic kidney disease (eGFR 48 mL/min/1.73 m²), and a history of myocardial infarction 3 years ago presents for diabetes optimization. His current HbA1c is 8.2% on metformin 1,000 mg BID. Which of the following is the most appropriate next step in his glycemic management per the ADA 2024 standards?
Loading your practice session…